Chunghong Medical (300981.SZ) announced its semi-annual report for 2024, with revenue of CNY 1.148 billion, a YoY increase of 14.97%; net income attributable to shareholders of listed companies was CNY 32.5299 million, reversing from a loss to a profit; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was - CNY 4.2721 million; basic earnings per share was CNY 0.0836.
中红医疗(300981.SZ)：上半年净亏损3252.99万元 同比扭亏
Zhonghong Medical (300981.SZ): a net loss of 325.299 million yuan in the first half of the year, turning around year-on-year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.